ConductScience.org, home

Paper20028854

AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity.

Chresta CM and 23 others. Cancer Res, 2010. Cited by 695 papers, by iCite.

Cite this record

ConductScience Library. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Papers, record 20028854. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20028854

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity.
PubMed
Journal
Cancer Res
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
695
iCite
Relative citation ratio, by iCite
15.6
iCite
Revised in PubMed
2023-08-15
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chresta CMChristine M
2Davies BRBarry R
3Hickson IIan
4Harding TTom
5Cosulich SSabina
6Critchlow SESusan E
7Vincent JPJohn P
8Ellston RRebecca
9Jones DDarren
10Sini PPatrizia
11James DDominic
12Howard ZZoe
13Dudley PPhillippa
14Hughes GGareth
15Smith LLisa
16Maguire SSharon
17Hummersone MMarc
18Malagu KKarine
19Menear KKeith
20Jenkins RRichard

Source PubMed

See all 24 authorsDownload CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
MorpholinesMajor topic
Neoplasms, ExperimentalMajor topic
Protein KinasesMajor topic
Signal TransductionMajor topic
Animals
Cell Proliferation
Female
Humans
Mice
Mice, Nude
Protein Kinase Inhibitors
TOR Serine-Threonine Kinases
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Cited by444

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 695 citations.

PMIDTitleJournalYearIn PapersSource
42943233Biological Effects of Umbelliferone in MCF-7 Breast Cancer Cells: Integrated In Vitro and Computational Analyses.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943233PubMed
42738804Exploring the Utility of ALDH1 as a Marker for the Cancer Stem Cell Population in OCCC Cell Lines.Cells2026https://conductscience.org/library/papers/42738804PubMed
42511704Advances in the Molecular Mechanisms of Cholangiocarcinoma: A Comprehensive Review of Biomarkers, Regulatory Pathways and Tumor Microenvironment Reprogramming.Int J Mol Sci2026https://conductscience.org/library/papers/42511704PubMed
42490445mTOR signaling contributes to system-driven rhythmic gene expression in mouse liver.Sci Adv2026https://conductscience.org/library/papers/42490445PubMed
42387647MET-associated immune prognostic signature predicts survival and guides personalized therapy in glioma.Acta Neuropathol Commun2026https://conductscience.org/library/papers/42387647PubMed
42310303Epithelial cell extrusion underlies starvation-induced cell loss in a sea anemone.Nat Commun2026https://conductscience.org/library/papers/42310303PubMed
42118332Targeting the GSK-3β/mTOR axis to overcome chemoresistance in gestational choriocarcinoma: molecular mechanisms and therapeutic opportunities.Cancer Chemother Pharmacol2026https://conductscience.org/library/papers/42118332PubMed
41931112Discovery of Autophagy Modulators that Increase I1061T NPC1 Expression and Promote Cholesterol Efflux in Niemann-Pick Type C Patient-Derived Fibroblasts.ACS Chem Biol2026https://conductscience.org/library/papers/41931112PubMed
41792142Functional genomics integration of glycolysis-related gene networks reveals prognostic biomarkers and immune microenvironment regulation in breast cancer.Sci Rep2026https://conductscience.org/library/papers/41792142PubMed
41615501Functional characterisation of Target of Rapamycin (TOR) signalling in Physcomitrella.Plant Cell Rep2026https://conductscience.org/library/papers/41615501PubMed
41590339Combination Cancer Therapy and Reference Models for Assessing Drug Synergy in Glioblastoma.Curr Oncol2025https://conductscience.org/library/papers/41590339PubMed
41561382United multi-omics and machine learning refine regulatory T cell-defined hepatocellular carcinoma subtypes.iScience2026https://conductscience.org/library/papers/41561382PubMed
41469379mTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics.Signal Transduct Target Ther2025https://conductscience.org/library/papers/41469379PubMed
41405991Liprin-α1 enhances PHLDB3 oncogenic function in colorectal cancer via activation of mTORC2-AKT1 pathway.Cell Rep2026https://conductscience.org/library/papers/41405991PubMed
41287790Unveiling disulfidptosis-linked lncRNA signatures: insights into the immune microenvironment and drug responsiveness in oral squamous cell carcinoma.Front Genet2025https://conductscience.org/library/papers/41287790PubMed
41170605Collagen Signaling via DDR1 Exacerbates Barriers to Macromolecular Drug Delivery in a 3D Model of Pancreatic Cancer Fibrosis.Small2025https://conductscience.org/library/papers/41170605PubMed
41085569Endometrial cancer: from clinical reality to molecular treatment.Discov Oncol2025https://conductscience.org/library/papers/41085569PubMed
41006635Nutrient-driven TOR signalling controls a chromatin-associated complex for orchestrating plant growth and stress tolerance.Nat Plants2025https://conductscience.org/library/papers/41006635PubMed
40747523Light-dark dependent changes in chloroplast and mitochondrial activity in Chlamydomonas reinhardtii.Front Plant Sci2025https://conductscience.org/library/papers/40747523PubMed
40715742Immunopharmacology of senescence: targeting the senescence-associated secretory phenotype (SASP)-a mechanism-based review.Inflammopharmacology2025https://conductscience.org/library/papers/40715742PubMed

See all 444 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
EIF4EBP11978PubTator's text mininghttps://conductscience.org/library/genes/1978NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
RPS6KB16198PubTator's text mininghttps://conductscience.org/library/genes/6198NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20028854

GET https://conductscience.org/api/papers/v1/20028854/authors?page=2